jdq443
Showing 1 - 7 of 7
Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult, KRAS G12C Trial (JDQ443)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- +2 more
- JDQ443
- (no location specified)
Aug 11, 2023
Small Cell Lung Carcinoma Trial in Orlando, San Antonio (JDQ443)
Suspended
- Small Cell Lung Carcinoma
- JDQ443
-
Orlando, Florida
- +1 more
Oct 17, 2022
KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small Cell Lung, NSCLC Trial (JDQ443, trametinib, Ribociclib)
Recruiting
- KRAS G12C Mutant Solid Tumors
- +10 more
- JDQ443
- +3 more
-
Boston, Massachusetts
- +5 more
Jan 11, 2023
Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression = 1% and an STK11
Recruiting
- Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
- JDQ443
-
Montpellier, France
- +7 more
Dec 19, 2022
NSCLC Trial (JDQ443)
Not yet recruiting
- NSCLC
- JDQ443
- (no location specified)
Feb 2, 2023
NSCLC Trial in Worldwide (JDQ443, docetaxel)
Recruiting
- Non-Small Cell Lung Cancer
- JDQ443
- docetaxel
-
Caba, Buenos Aires, Argentina
- +34 more
Dec 19, 2022
KRAS G12C Mutant Solid Tumors, NSCLC, Carcinoma, Colorectal Trial in Worldwide (JDQ443, TNO155, tislelizumab)
Recruiting
- KRAS G12C Mutant Solid Tumors
- +9 more
- JDQ443
- +2 more
-
Atlanta, Georgia
- +31 more
Jul 7, 2022